Epidemiology
170 metody
2 rodiny metod
NEJVÍCE PROPOJENÉ V OBORU EPIDEMIOLOGY
Zobrazuje se 170 z 170 metody
Clinical / epidemiology166 metody
Adaptive case seriesAdaptive Case-Control StudyAdaptive Cohort StudyAdaptive Competing Risks AnalysisAdaptive Cox Proportional HazardsAdaptive Cross-Sectional Epidemiological StudyAdaptive Diagnostic Accuracy StudyAdaptive Dose-Response AnalysisAdaptive Ecological StudyAdaptive nested case-controlAdaptive Phase I Clinical TrialAdaptive Phase II Clinical TrialAdaptive Phase III clinical trialAdaptive Phase IV studyAdaptive Randomized Clinical TrialAdaptive screening test evaluationAdaptive Survival AnalysisBayesian Case SeriesBayesian Case-Control StudyBayesian Case-Crossover DesignBayesian Cohort StudyBayesian Competing Risks AnalysisBayesian Cox Proportional HazardsBayesian Diagnostic Accuracy StudyBayesian Dose-Response AnalysisBayesian Ecological StudyBayesian Kaplan-Meier analysisBayesian nested case-controlBayesian Phase I clinical trialBayesian Phase II Clinical TrialBayesian Phase III Clinical TrialBayesian Phase IV studyBayesian Randomized Clinical TrialBayesian Screening Test EvaluationCase seriesCase-control studyCase-crossover designCohort StudyCox proportional hazardsCross-sectional epidemiological studyDose-Response AnalysisEcological StudyKaplan-Meier AnalysisMatched case reportMatched case-control studyMatched Case-Crossover DesignMatched Cohort StudyMatched Competing Risks AnalysisMatched Cox Proportional HazardsMatched Cross-Sectional Epidemiological StudyMatched Diagnostic Accuracy StudyMatched dose-response analysisMatched ecological studyMatched Kaplan-Meier AnalysisMatched nested case-controlMatched Phase II clinical trialMatched Phase III Clinical TrialMatched Phase IV StudyMatched Randomized Clinical TrialMatched Screening Test EvaluationMatched Survival AnalysisMeta-analytic case reportMeta-analytic Case SeriesMeta-analytic case-control studyMeta-analytic case-crossover designMeta-analytic Cohort StudyMeta-analytic competing risks analysisMeta-analytic Cox proportional hazardsMeta-analytic cross-sectional epidemiological studyMeta-analytic Diagnostic Accuracy StudyMeta-analytic dose-response analysisMeta-analytic Ecological StudyMeta-analytic Kaplan-Meier analysisMeta-analytic Nested Case-ControlMeta-analytic Phase I clinical trialMeta-analytic Phase II clinical trialMeta-analytic Phase III Clinical TrialMeta-analytic Phase IV StudyMeta-analytic Randomized Clinical TrialMeta-analytic Screening Test EvaluationMeta-analytic survival analysisMulticenter case reportMulticenter case seriesMulticenter Case-Control StudyMulticenter Case-Crossover DesignMulticenter cohort studyMulticenter Competing Risks AnalysisMulticenter Cox proportional hazardsMulticenter Diagnostic Accuracy StudyMulticenter Dose-Response AnalysisMulticenter Ecological StudyMulticenter Kaplan-Meier analysisMulticenter Nested Case-ControlMulticenter Phase I Clinical TrialMulticenter phase II clinical trialMulticenter Phase III Clinical TrialMulticenter Phase IV StudyMulticenter Randomized Clinical TrialMulticenter Screening Test EvaluationNested case-controlPhase I Clinical TrialPhase II clinical trialPhase III clinical trialPhase IV studyPragmatic case seriesPragmatic case-control studyPragmatic Cross-Sectional Epidemiological StudyPragmatic diagnostic accuracy studyPragmatic Dose-Response AnalysisPragmatic ecological studyPragmatic Kaplan-Meier analysisPragmatic nested case-controlPragmatic phase II clinical trialPragmatic phase III clinical trialPragmatic phase IV studyPragmatic randomized clinical trialPragmatic Screening Test EvaluationPragmatic survival analysisProspective Case SeriesProspective Case-Control StudyProspective Case-Crossover DesignProspective Cohort StudyProspective Competing Risks AnalysisProspective Cox proportional hazardsProspective Diagnostic Accuracy StudyProspective Dose-Response AnalysisProspective Ecological StudyProspective Nested Case-ControlProspective Phase IV StudyProspective Randomized Clinical TrialProspective Screening Test EvaluationProspective Survival AnalysisRandomized clinical trialRetrospective Case ReportRetrospective Case SeriesRetrospective case-control studyRetrospective Cohort StudyRetrospective competing risks analysisRetrospective Cox proportional hazardsRetrospective cross-sectional epidemiological studyRetrospective diagnostic accuracy studyRetrospective Ecological StudyRetrospective Kaplan-Meier AnalysisRetrospective nested case-controlRetrospective phase II clinical trialRetrospective phase III clinical trialRetrospective survival analysisRisk-adjusted case seriesRisk-adjusted case-control studyRisk-adjusted case-crossover designRisk-adjusted cohort studyRisk-adjusted competing risks analysisRisk-adjusted Cox Proportional HazardsRisk-adjusted cross-sectional epidemiological studyRisk-adjusted diagnostic accuracy studyRisk-adjusted dose-response analysisRisk-adjusted ecological studyRisk-adjusted Kaplan-Meier analysisRisk-adjusted Nested Case-ControlRisk-adjusted Phase I clinical trialRisk-adjusted Phase II clinical trialRisk-adjusted Phase III clinical trialRisk-adjusted Phase IV studyRisk-adjusted screening test evaluationRisk-adjusted survival analysisScreening Test Evaluation
Epidemic modelling4 metody